Sponsored by an educational grant from Ipsen
The interest of the medical community in age-related endocrine deficiencies is increasing in parallel to the aging population. Much attention has recently been given to the concept that testosterone falls progressively with age and that a significant percentage of men over the age of 60 years have serum Hospital of the University testosterone levels that are below the lower limits of young adult (age 20-30 years) men, a biochemically induced clinical syndrome that is now described in the literature as late-onset hypogonadism (LOH). With serious symptoms like reduced mood or cognition, sexual dysfunction, increased body fat and a greater risk of osteoporosis, LOH can have a big impact on a man's short- and long-term health: mind, body, spirit. Testosterone substitution is an effective way to manage this condition. Misdiagnoses, lack of knowledge, and safety concerns are some of the reasons why LOH goes untreated. Once patients begin treatment with testosterone substitution, follow-up and monitoring is essential.
In this symposium, a panel of experts will discuss the latest evidence on the benefits and safety of testosterone therapy on a hypogonadal man's mind, body, spirit, and more specifically on his body functions, on his brain and cognitive functions, on his erectile physiology and on his overall quality of life.
Copyright © 2006 ISSAM